Elías Campo

Director de l'IDIBAPS i de la FCRB

Publicacions destacades

  • CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1- mantle cell lymphoma

    Autors: Martín-Garcia D, Navarro A, Valdés-Mas R, Clot G, Gutiérrez-Abril J, Prieto M, Ribera-Cortada I, Woroniecka R, Rymkiewicz G, Bens S, de Leval L, Rosenwald A, Ferry JA, Hsi ED, Fu K, Delabie J, Weisenburger D, de Jong D, Climent F, O'Connor SJ, Swerdlow SH, Torrents D, Beltran S, Espinet B, González-Farré B, Veloza L, Costa D, Matutes E, Siebert R, Ott G, Quintanilla-Martinez L, Jaffe ES, López-Otín C, Salaverria I, Puente XS, Campo E, Beà S .
    Referència: BLOOD 2019; 133(9):940-951.
  • A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome.

    Autors: Clot G, Jares P, Giné E, Navarro A, Royo C, Pinyol M, Martín-Garcia D, Demajo S, Espinet B, Salar A, Ferrer A, Muntañola A, Aymerich M, Rauert-Wunderlich H, Jaffe ES, Connors JM, Gascoyne RD, Delabie J, López-Guillermo A, Ott G, Wright GW, Staudt LM, Rosenwald A, Scott DW, Rimsza LM, Beà S, Campo E .
    Referència: BLOOD 2018; 132(4):413-422.
  • Clinical impact of the subclonal architecture and mutational complexity in chronic lymphocytic leukemia.

    Autors: Nadeu F, Clot G, Delgado J, Martín-García D, Baumann T, Salaverria I, Beà S, Pinyol M, Jares P, Navarro A, Suárez-Cisneros H, Aymerich M, Rozman M, Villamor N, Colomer D, González M, Alcoceba M, Terol MJ, Navarro B, Colado E, Payer ÁR, Puente XS, López-Otín C, López-Guillermo A, Enjuanes A, Campo E .
    Referència: LEUKEMIA 2018; 32(3):645-653.
  • Cyclin D1 overexpression induces global transcriptional downregulation in lymphoid neosplasms.

    Autors: Albero R, Enjuanes A, Demajo S, Castellano G, Pinyol M, García N, Capdevila C, Clot G, Suárez-Cisneros H, Shimada M, Karube K, López-Guerra M, Colomer D, Beà S, Martin-Subero JI, Campo E, Jares P .
    Referència: JOURNAL OF CLINICAL INVESTIGATION 2018; 128(9):4132-4147.
  • Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets.

    Autors: Karube K, Enjuanes A, Dlouhy I, Jares P, Martin-Garcia D, Nadeu F, Ordóñez GR, Rovira J, Clot G, Royo C, Navarro A, Gonzalez-Farre B, Vaghefi A, Castellano G, Rubio-Perez C, Tamborero D, Briones J, Salar A, Sancho JM, Mercadal S, Gonzalez-Barca E, Escoda L, Miyoshi H, Ohshima K, Miyawaki K, Kato K, Akashi K, Mozos A, Colomo L, Alcoceba M, Valera A, Carrió A, Costa D, Lopez-Bigas N, Schmitz R, Staudt LM, Salaverria I, López-Guillermo A, Campo E .
    Referència: LEUKEMIA 2018; 32(3):675-684.
  • The 2016 revision of the World Health Organization classification of lymphoid neoplasms

    Autors: Swerdlow S.H., Campo E., Pileri S.A., Lee Harris N., Stein H., Siebert R., Advani R., Ghielmini M., Salles G.A., Zelenetz A.D., Jaffe E.S..
    Referència: BLOOD 2016; 127(20):2375-2390.
  • Non-coding recurrent mutations in chronic lymphocytic leukaemia

    Autors: Puente XS, Beà S, Valdés-Mas R, Villamor N, Gutiérrez-Abril J, Martín-Subero JI, Munar M, Rubio-Pérez C, Jares P, Aymerich M, Baumann T, Beekman R, Belver L, Carrio A, Castellano G, Clot G, Colado E, Colomer D, Costa D, Delgado J, Enjuanes A, Estivill X, Ferrando AA, Gelpí JL, González B, González S, González M, Gut M, Hernández-Rivas JM, López-Guerra M, Martín-García D, Navarro A, Nicolás P, Orozco M, Payer ÁR, Pinyol M, Pisano DG, Puente DA, Queirós AC, Quesada V, Romeo-Casabona CM, Royo C, Royo R, Rozman M, Russiñol N, Salaverría I, Stamatopoulos K, Stunnenberg HG, Tamborero D, Terol MJ, Valencia A, López-Bigas N, Torrents D, Gut I, López-Guillermo A, López-Otín C, Campo E .
    Referència: NATURE 2015; 526(7574):519-524.
  • Landscape of somatic mutations and clonal evolution in mantle cell lymphoma

    Autors: Bea, Silvia; Navarro, Alba; Salaverria, Itziar; Martin-Garcia, David; Jares, Pedro; Gine, Eva; Nadeu, Ferran; Conde, Laura; Juan, Manel; Clot, Guillem; Lopez-Guerra, Monica; Moros, Alexandra; Roue, Gael; Aymerich, Marta; Villamor, Neus; Martinez, Antonio; Valera, Alexandra; Amador, Virginia; Hernandez, Luis; Rozman, Maria; Colomer, Dolors; Lopez-Guillermo, Armando; Campo, Elias.
    Referència: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 2013; 110(45):18250-18255.
  • Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia

    Autors: Pinyol M; Conde, Laura; Villamor, Neus; Jares, Pedro; Bea, Silvia; Juan, Manel; Lopez-Guerra, Monica; Colomer, Dolors; Navarro, Alba; Aymerich, Marta; Rozman, Maria; Hernandez, Jesus M; Hernandez L; Yaguee, Jordi; de Sanjose, Silvia; Lopez-Guillermo, Armando; Montserrat, Emili; Campo, Elias.
    Referència: NATURE 2011; 475(7354):101-105.

Projectes destacats

  • Molecular Diagnosis, Prognosis, and Therapeutic Targets in Mantle Cell Lymphoma

    Investigador/a principal: Elías Campo Güerri
    Finançador: NATIONAL INSTITUT OF HEALTH (NHI)
    Codi: 1P01CA229100
    Durada: 01/09/2019 - 31/08/2023
  • Single-cell genomics to comprehensively understand healthy B-cell maturationand transformation to chronic lymphocytic leukemia (BCLL@las)

    Investigador/a principal: Elias Campo
    Finançador: EUROPEAN COMMISSION ; EUROPEAN RESEARCH COUNCIL (ERC), EUROPEAN COMMISSION
    Codi: H2020-ERC-Sy_2018 (810287)
    Durada: 01/04/2019 - 31/03/2023
  • Genomic and epigenomic drivers of disease evolution in chronic lymphocytic leukemia. Targets for clinical intervention

    Investigador/a principal: Elías Campo Güerri
    Finançador: LA CAIXA FOUNDATION (Programa Financiador competitivo)
    Codi: CLLEvolution-HR17-00221
    Durada: 31/12/2018 - 30/12/2021
  • EUCANCan: a federated network of aligned and interoperable infrastructures for the homogeneous analysis, management and sharing of genomic oncology data for Personalised Medicine

    Investigador/a principal: Elías Campo Güerri
    Finançador: EUROPEAN COMMISSION (PROGRAMA HORIZON 2020). (Programa Financiador competitivo)
    Codi: EUCANCANCER
    Durada: 01/01/2019 - 31/12/2022
  • La Medicina Personalitzada a Catalunya-Càncer (MedPerCan). Estudi pilot sobre l'impacte de l'anàlisi genòmica en la pressa de decisions en oncologia

    Investigador/a principal: Manel Esteller Badosa, Gabriel Capellá Munar
    Finançador: PERIS PROJECTE (Programa Financiador competitivo)
    Codi: SLT002/16/00374
    Durada: 01/01/2017 - 31/12/2019